Cite

    Nguyễn, T., Maria, A. T. J., Ladhari, C., Palassin, P., Quantin, X., Lesage, C., Taïeb, G., Ayrignac, X., Rullier, P., Hillaire-Buys, D., Lambotte, O., Guilpain, P., & Faillie, J. (2022). rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database. Annals of the rheumatic diseases, 81(2), e32. http://access.bl.uk/ark:/81055/vdc_100148628643.0x000057